Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Natural History Study of Neurodegeneration and Optic Atrophy Caused by Ferredoxin Reductase Mutations in Pediatric and Adult Patients

NCT04580979 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT04580979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04580979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Natural History Study of Neurodegeneration and Optic Atrophy Caused by Ferredoxin Reductase Mutations in Pediatric and Adult Patients
Lead sponsor
State University of New York at Buffalo
Phase
Observational
Overall status
Completed
Start date
November 3, 2020
Completion date
August 17, 2023
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitochondrial diseases, neurodegenerative disease, hereditary, optic atrophy